Effect of propionic and methylmalonic acids on the in vitro phosphorylation of intermediate filaments from cerebral cortex of rats during development.
In this study we investigated the in vivo and in vitro effects of methylmalonic (MMA) and propionic acids (PA), at concentrations usually found in methylmalonic acidemia and propionic acidemia respectively, on the phosphorylation of intermediate filament proteins in cerebral cortex of rats during development. Rats of 9, 12, and 17 days were acutely injected with the acids and sacrificed 90 min after injection. The cerebral cortex was dissected, and slices were incubated with 32P-orthophosphate. The cytoskeletal fraction was extracted and the radioactivity incorporated into intermediate filament subunits was measured. In addition, cortical slices from nontreated rats of 9, 12, 15, 17, 21, and 60 days of life were incubated with the acids in the presence of 32P-orthophosphate, the cytoskeletal fraction was extracted and the radioactivity was measured. Results demonstrated that MMA and PA significantly decreased the radioactivity incorporated into intermediate filament proteins at day 12, both in vivo and in tissue slices. In contrast, PA increased the in vitro phosphorylation of the cytoskeletal proteins in slices of 21-day-old animals. It acts through PP2A and PP2B in 12-day-old rats and through PKA and PKCaMII in 21-day-old animals. We propose that alteration of cytoskeletal protein phosphorylation caused by methylmalonic and propionic acids may be related to the neurological dysfunction characteristic of propionic and methylmalonic acidemia.
Universidade Federal do Rio Grande do Sul, Instituto de Ciências Básicas da Saude, Departamento de Bioquímica, Rua Ramiro Barcelos 2600 anexo, 90035-003 Porto Alegre, RS, Brazil.
Lúcia Maria Vieira
LM
de Almeida
Cláudia
C
Funchal
Priscila de Lima
Pde L
Pelaez
Franciele Dall Bello
FD
Pessutto
Samanta Oliveira
SO
Loureiro
Lilian
L
Vivian
Moacir
M
Wajner
Regina
R
Pessoa-Pureur
D000818:Animals; D002540:Cerebral Cortex / Q000187:drug effects / Q000254:growth & development* / Q000378:metabolism*; D003598:Cytoskeletal Proteins / Q000378:metabolism; D004591:Electrophoresis, Polyacrylamide Gel; D066298:In Vitro Techniques; D007382:Intermediate Filaments / Q000378:metabolism*; D008764:Methylmalonic Acid / Q000494:pharmacology*; D010744:Phosphoric Monoester Hydrolases / Q000378:metabolism; D010766:Phosphorylation; D011422:Propionates / Q000494:pharmacology*; D017346:Protein Serine-Threonine Kinases / Q000502:physiology; D051381:Rats; D017208:Rats, Wistar
D003598:Cytoskeletal Proteins; D011422:Propionates; D008764:Methylmalonic Acid; D017346:Protein Serine-Threonine Kinases; D010744:Phosphoric Monoester Hydrolases; C029658:propionic acid